Showing results (51-60 of 247) with videos related to

Sort By:
Pageof 25
European Journal of Biochemistry|January 1, 1981
Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptorJ Zapf, E Schoenle, M Waldvogel, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1992
Prostaglandin E2 stimulates synthesis of insulin-like growth factor binding protein-3 in rat bone cells in vitroC Schmid, I Schläpfer, M Waldvogel, et al.
Trends in Endocrinology and Metabolism: TEM|May 1, 1990
Therapeutic potential of insulinlike growth factor iE R Froesch, H P Guler, C Schmid, et al.
Acta Endocrinologica|February 1, 1987
Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observationsG A Spinas, J Zapf, A M Landolt, et al.
Acta Endocrinologica|July 1, 1989
Insulin-like growth factor I increase glomerular filtration rate and renal plasma flow in manH P Guler, K U Eckardt, J Zapf, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1990
Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor IK Binz, P Joller, P Froesch, et al.
Biochemical and Biophysical Research Communications|July 6, 1995
Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growthC Schmid, I Schläpfer, A Keller, et al.
The New England Journal of Medicine|November 10, 1983
Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngiomaH Bucher, J Zapf, T Torresani, et al.
Progress in Growth Factor Research|January 1, 1995
Expression, effects, and fate of IGFBP-5 are different in normal and malignant osteoblastic cellsC Schmid, I Schläpfer, M A Gosteli-Peter, et al.
The Journal of Clinical Investigation|May 1, 1979
Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier proteinJ Zapf, E Schoenle, G Jagars, et al.
Pageof 25